Tunnel Construction Course Pilot Assessment of Simulation-based Training Effectiveness (TCC-PASTE)

June 24, 2020 updated by: HelpMeSee Inc.
TCC-PASTE is a randomised controlled trial comparing a simulation based training curriculum with standard training for ophthalmology residents learning to perform tunnel construction in manual small incision cataract surgery. After obtaining informed consent, participating trainees will be randomly assigned to learn to perform tunnel construction either through the simulation based curriculum or through the standard curriculum at their institute. Trainees assigned to simulation will learn through studying an eBook, participating in training sessions supported by repeated practice on a virtual reality simulator, and supervised training in live surgery to facilitate transfer of skill acquired in simulation to the operating room. To determine the effect of simulation based training, we will assess the number of errors trainees perform in the initial part of their intraoperative learning curve.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10018
        • HelpMeSee Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Enrolled in a training program at a partner institute;
  • No or minimal prior experience with MSICS (trainees within the first 2-3 months of matriculation, or having performed fewer than 20 procedures as the main surgeon but no more than 5 MSICS procedures within 6 months preceding participation in TCC-PASTE);
  • Provide informed consent to participate in the study;
  • Able to participate in routine patient care activities, as required by the partner institute, without the need to take overnight call for the duration corresponding to the simulation training phase.

Exclusion Criteria:

  • Performed scleral tunnel construction as the main surgeon in 20 or more procedures;
  • Prior experience with the HelpMeSee simulator or participation in the HelpMeSee simulation training curriculum.
  • Required to take overnight call for the duration corresponding to simulation training phase.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Simulation based curriculum

Three phases:

  1. Self-study of an eBook - Participating trainees will be required to learn material pertaining to tunnel construction and general surgical principles during SICS from an eBook that has been developed by HelpMeSee.
  2. Instructor led teaching - didactic training, lab activities to gain familiarity with instruments, simulator based training through deliberate practice, and debriefing with instructor.
  3. Instructor supervised performance of surgery on patients in the operating room.
See arm/group description
Active Comparator: Standard training
Current standard curriculum for resident training.
See arm/group description

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total surgical errors
Time Frame: 12 weeks
Incidence of pre-specified errors during tunnel construction through video-based assessment: uveal prolapse (UP), buttonhole incision (BI), premature entry (PE), Descemet's detachment (DD), laceration of upper wall (UL), laceration of lateral walls of tunnel (LL), corneal endothelial touch (ET), contact with iris, (IC) and contact with the lens (LC).
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major surgical errors
Time Frame: 12 weeks
Incidence of pre-specified errors during tunnel construction through video-based assessment: uveal prolapse (UP), buttonhole incision (BI), premature entry (PE), Descemet's detachment (DD), laceration of upper wall (UL), laceration of lateral walls of tunnel (LL).
12 weeks
Minor surgical errors
Time Frame: 12 weeks
Incidence of pre-specified errors during tunnel construction through video-based assessment: corneal endothelial touch (ET), contact with iris, (IC) and contact with the lens (LC).
12 weeks
Surgical product/outcome assessment: scleral groove
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Surgical product/outcome assessment: tunnel dissection
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Surgical product/outcome assessment: paracentesis
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Surgical product/outcome assessment: viscoelastic injection/exchange
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Surgical product/outcome assessment: keratome entry and extensions
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Overall technical skill for tunnel construction
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Technical skill: scleral groove
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Technical skill: tunnel dissection
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Technical skill: paracentesis
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Technical skill: viscoelastic injection/exchange
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Technical skill: keratome entry and extensions
Time Frame: 12 weeks
Custom developed structured rating scale; video-based assessment
12 weeks
Task-specific technical skill: scleral tunnel
Time Frame: 12 weeks
ICO-OSCAR:SICS; video-based assessment
12 weeks
Task-specific technical skill: corneal entry
Time Frame: 12 weeks
ICO-OSCAR:SICS; video-based assessment
12 weeks
Task-specific technical skill: paracentesis & viscoelastic exchange
Time Frame: 12 weeks
ICO-OSCAR:SICS; video-based assessment
12 weeks
Global technical skill
Time Frame: 12 weeks
Global indices in ICO-OSCAR:SICS; video-based assessment
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of any surgical error or self-reported intervention by supervising surgeon to prevent error
Time Frame: 12 weeks
Any physical intervention or assistance by supervising surgeon is counted as an additional error
12 weeks
Incidence of major surgical error or self-reported intervention by supervising surgeon to prevent error
Time Frame: 12 weeks
Any physical intervention or assistance by supervising surgeon is counted as an additional error
12 weeks
Incidence of minor surgical error or self-reported intervention by supervising surgeon to prevent error
Time Frame: 12 weeks
Any physical intervention or assistance by supervising surgeon is counted as an additional error
12 weeks
Incidence of any physical intervention or assistance by supervising surgeon
Time Frame: 12 weeks
Each instance of physical intervention or assistance by supervising surgeon is counted as one event.
12 weeks
Incidence of complete intervention or assistance by supervising surgeon
Time Frame: 12 weeks
Each instance of ake-over by supervising surgeon for the specific activity or rest of task is counted as one event.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2018

Primary Completion (Actual)

August 16, 2019

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

June 19, 2020

First Submitted That Met QC Criteria

June 24, 2020

First Posted (Actual)

June 29, 2020

Study Record Updates

Last Update Posted (Actual)

June 29, 2020

Last Update Submitted That Met QC Criteria

June 24, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TCCPASTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Simulation based curriculum

Subscribe